Karius logo

Karius Funding & Investors

Karius, Inc. operates as a life science company. The Company provides diagnostic tests and clinical data facilities. Karius also transforms infectious disease diagnostics by providing a validated test that can detect bacteria, DNA viruses, and eukaryotic pathogens including yeasts, molds, and protozoa. Karius serves markets in the United States.

kariusdx.com

Total Amount Raised: $354,000,000

Karius Funding Rounds

  • Series B

    $165,000,000

    Series B Investors

    SoftBank Vision Fund
    General Catalyst
    Lightspeed Venture Partners
    Khosla Ventures
    HBM Healthcare Investments
  • Debt Financing

    $25,000,000

    Debt Financing Investors

    Oxford Finance
  • Series A

    $59,000,000

    Series A Investors

    Data Collective (DCVC)
    Lightspeed Venture Partners
    Khosla Ventures
    Tencent
    Innovation Endeavors
    S28 Capital
    Pacific 8 Ventures
    aMoon Fund
  • Series C

    $100,000,000

    Series C Investors

    5am Ventures
    Gilde Healthcare
    Khosla Ventures
    Innovation Endeavors
    Waycross Ventures
    SoftBank Vision Fund
    HBM Healthcare Investments
    General Catalyst
    Blue Water Life Science Fund
    Seventure Partners
  • Seed

    $5,000,000

    Seed Investors

    Data Collective (DCVC)
    Lightspeed Venture Partners
    Innovation Endeavors
Funding info provided by Diffbot.